A. Carpentier et al., DISTINCT SENSITIVITY OF NEUROBLASTOMA-CELLS FOR RETINOID RECEPTOR AGONISTS - EVIDENCE FOR FUNCTIONAL RECEPTOR HETERODIMERS, Oncogene, 15(15), 1997, pp. 1805-1813
Retinoic acid (RA) plays a major role in embryogenesis of the nervous
system and has been reported to induce differentiation in neuroblastom
a cell lines. To identify RA signaling pathways involved in such diffe
rentiation processes, two RA-sensitive neuroblastoma cell lines (LA-N-
5 and SH-SY5Y) were extensively studied. Northern blot experiments det
ermined that of the three RAR mRNAs, only RAR alpha was significantly
expressed, with respectively weak or undetectable levels of RAR gamma
and RAR beta. RXRs (alpha and beta) receptors were weakly expressed, W
estern blotting analysis confirmed the constitutive expression of RAR
alpha and absence of RAR beta and weak levels of RXR alpha. Treatment
with all-trans-RA up-regulated RAR alpha and induced a drastic increas
e of RAR beta (both at the RNA and protein level). To further characte
rize the function of RAR alpha, RAR beta and RXR alpha in NB cells, nu
clear extracts from LA-N-5 cells were analysed by EMSA studies. Three
specific retarded complexes were observed which were significantly dec
reased or shifted in the presence of monoclonal antibodies to RAR alph
a, RAR beta and RXR alpha. RA treatment dramatically induced a DR5-bin
ding RXR alpha-RAR beta heterodimer. Treatment with combinations of RA
R alpha or RAR beta agonists with a RXR alpha agonist or with a RAR al
pha agonist alone, induced neurite-outgrowth supporting the probabilit
y that both RXR alpha-RAR alpha or RXR alpha-RAR beta heterodimers are
involved in RA-mediated differentiation of NB cells. The availability
of novel synthetic RA-specific receptor ligands should provide the po
ssibility of tissue specific therapeutic regimes.